SLC5A5 and neoplasm: Visualization of NIS-expressing cells using a radiopharmaceutical and scintigraphy forms the basis for currently actively developed virotherapy and mesenchymal stem cell therapy approaches, where transfection with the NIS gene allows for tracking the spread of the oncolytic viral vector throughout the body, as well as assessing the degree of virus propagation in the tumor [5].